Clinical trials on early detection of colorectal, prostate and breast cancers.

The daughter company of Montreal EpiTerapia, Canada-Kazakhstan EpiTerapia Inc (Canada), the Institute of General Oncology and Cytology (Kazakhstan), Kazakh research institute of Oncology/Radiology (Kazakhstan) and HKGepitherapeutics (Honk Kong)  signed the agreement on the beginning of clinical trials for early detection of colorectal, prostate and breast cancers  with non-invasive method based on DNA methylation of circulated tumor DNA.